National Cancer Institute (U.S.)
"National Cancer Institute (U.S.)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937.
| Descriptor ID |
D054547
|
| MeSH Number(s) |
I01.409.418.750.600.650.496.150 N03.540.052.750.150 N03.540.348.500.500.600.650.496.150
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "National Cancer Institute (U.S.)".
Below are MeSH descriptors whose meaning is more specific than "National Cancer Institute (U.S.)".
This graph shows the total number of publications written about "National Cancer Institute (U.S.)" by people in this website by year, and whether "National Cancer Institute (U.S.)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2017 | 2 | 5 | 7 |
| 2018 | 1 | 3 | 4 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "National Cancer Institute (U.S.)" by people in Profiles.
-
COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living With HIV: The Experience of Grantees of the US National Cancer Institute. Nicotine Tob Res. 2021 08 18; 23(9):1629-1632.
-
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. Neuro Oncol. 2021 08 02; 23(8):1252-1260.
-
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective. Cancer Discov. 2021 08; 11(8):1881-1885.
-
Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute. Support Care Cancer. 2021 Oct; 29(10):6005-6012.
-
Lessons learned from the delivery of virtual integrative oncology interventions in clinical practice and research during the COVID-19 pandemic. Support Care Cancer. 2021 Aug; 29(8):4191-4194.
-
Assessing the immediate impact of COVID-19 on surgical oncology practice: Experience from an NCI-designated Comprehensive Cancer Center in the Northeastern United States. J Surg Oncol. 2021 Jul; 124(1):7-15.
-
US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer. JAMA Oncol. 2021 02 01; 7(2):199-205.
-
The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV. Nicotine Tob Res. 2021 01 22; 23(2):407-410.
-
Chest imaging representing a COVID-19 positive rural U.S. population. Sci Data. 2020 11 24; 7(1):414.
-
Cancer Information-seeking in an Age of COVID-19: Findings from the National Cancer Institute's Cancer Information Service. Health Commun. 2021 Jan; 36(1):89-97.